Home › Therapeutic areas › Dermatology › Hidradenitis Suppurativa

Hidradenitis Suppurativa (7 companies)

Companies with an active program in Hidradenitis Suppurativa.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
CRVS Corvus Pharmaceuticals DermatologyOncology+1 Rare 1 Phase 3 $858M 7
KYMR Kymera Therapeutics DermatologyImmunology+1 Rare 1 Phase 2 $10.4B 5
GLUE Monte Rosa Therapeutics CardiovascularDermatology+3 Rare 1 Phase 2 $775M 7
MLTX MoonLake Immunotherapeutics DermatologyImmunology Rare 1 NDA Submitted $957M 4
ORKA Oruka Therapeutics DermatologyImmunology Rare 1 Phase 2 $6.53B 7
SYRE Spyre Therapeutics DermatologyImmunology Rare 1 Phase 2 $8.91B 10
TTRX Turn Therapeutics DermatologyInfectious Disease Rare 1 Phase 2 $261M 4